Abstract-Striatin is a novel protein that interacts with steroid receptors and modifies rapid, nongenomic activity in vitro. We tested the hypothesis that striatin would in turn affect mineralocorticoid receptor function and consequently sodium, water, and blood pressure homeostasis in an animal model. We evaluated salt sensitivity of blood pressure in novel striatin heterozygote knockout mice. Compared with wild type, striatin heterozygote exhibited a significant increase in blood pressure when sodium intake was increased from restricted (0.03%) to liberal (1.6%) sodium. Furthermore, renal expression of mineralocorticoid receptor and its genomic downstream targets serum/glucocorticoid-regulated kinase 1, and epithelial sodium channel was increased in striatin heterozygote versus wild-type mice on liberal sodium intake while the pAkt/Akt ratio, readout of mineralocorticoid receptor's rapid, nongenomic pathway, was reduced. To determine the potential clinical relevance of these findings, we tested the association between single nucleotide polymorphic variants of striatin gene and salt sensitivity of blood pressure in 366 white hypertensive subjects. HapMap-derived tagging single nucleotide polymorphisms identified an association of rs2540923 with salt sensitivity of blood pressure (odds ratio, 6.25; 95% confidence interval, 1.7-20; P=0.01). These data provide the first in vivo evidence in humans and rodents that associates striatin with markers of mineralocorticoid receptor activity. The data also support the hypothesis that the rapid, nongenomic mineralocorticoid receptor pathway (mediated via striatin) has a role in modulating the interaction between salt intake and blood pressure. (Hypertension.
I
nterventional and epidemiological studies have demonstrated an association between dietary sodium consumption and increases in blood pressure (BP). [1] [2] [3] However, ≈40% of individuals with hypertension do not demonstrate salt sensitivity (SS) of BP, and even in those with SS of BP the underlying mechanism(s) remain largely unknown. To better understand the differential BP response to sodium loading, one promising approach is to study the interaction of dietary sodium intake with candidate genes involved in the regulation of salt and water homeostasis.
A primary role of aldosterone and the mineralocorticoid receptor (MR) is to maintain sodium and water homeostasis. Activation of this process is initiated by translocation of an activated aldosterone/MR to the cell nucleus to modulate the expression of genes regulating electrolyte and fluid balance. 4 It has been documented that aldosterone activation of MR can also lead to rapid phosphorylation and activation of proteins in the MAPK pathways and increases in reactive oxygen species and intracellular calcium, among other effects. 5, 6 Together these effects are commonly referred to as aldosterone's nongenomic actions. Several other steroid hormone receptors, eg, estrogen receptor-α, have been shown to have both genomic and nongenomic effects. 7, 8 Striatin is a newly described protein that interacts with the estrogen receptor-α and MR and regulates their nongenomic actions. 9, 10 Striatin is a highly conserved member of the WD-repeat family of proteins that possesses caveolin-1, calcium-calmodulin, and coil-coil conserved domains. 11, 12 Our laboratory has reported that activation of MR by aldosterone increases striatin expression in kidney, heart and aortic tissue, and cultured endothelial cells. 13 Our group has also described that striatin is a novel mediator for aldosterone's induction of phospho-extracellular signal-regulated kinases and rapid action of estrogen receptor-α to promote phosphorylation of endothelial nitric oxide synthase. generated a novel striatin heterozygous knockout mouse and demonstrated that reduction in striatin levels results in SS of BP. To translate these results to human hypertension, we explored whether genetic variance within the striatin gene was associated with SS of BP in a well-phenotyped white hypertensive cohort.
Methods

Generation of Striatin Heterozygous Mouse and Experimental Protocol
The striatin heterozygous knockout strain (Strn +/− , CSD26933) was generated by the trans-National Institutes of Health Knockout Mouse Project. Details are available in the online-only Data Supplement.
BP Measurements
Details are available in the online-only Data Supplement.
Plasma Hormone Measurements
Blood was collected in purple-top BD Microtainer tubes (EDTA), and plasma was separated by centrifugation. Aldosterone levels were measured using Coat-A-Count Radioimmunometric Assay kit (SIEMENS, Los Angeles, CA). 15 Plasma renin activity was measured by radioimmunometric assay (DiaSorin, Stillwater, MN). 16 
Western Blot Analysis
Protein was extracted from heart, kidney, and adrenal tissue by homogenizing according to the Bullet Blender protocol and bead specification (Next Advance, Inc., Averill Park, NY). Briefly, 30 mg of tissue was placed in a radioimmunoprecipitation assay buffer (Boston Bioproducts, Worcester, MA) with protease inhibitor cocktail (SIGMA, St. Louis, MO; 1:100). Lysates were centrifuged at 12 000g for 10 minutes at 4°C, and supernatant was collected and stored at −20°C. Cell lysates were prepared with 4× reducing Laemmli's SDS sample buffer (250 MM Tris-HCl, 8% SDS, 40% glycerol, 0.02% bromophenol blue, dithiothreitol). Samples were size fractionated by electrophoresis on SDS-PAGE and proteins transferred to nitrocellulose membranes by electroblotting. Blots were incubated with primary antibody overnight at 4°C (BD Biosciences: striatin; Santa Cruz: epithelial sodium channel [ENaC], serum/glucocorticoid-regulated kinase 1 [SGK1], eNOS, and cell signaling: pAkt/Akt). Blots were incubated with conjugated secondary antibody with horseradish peroxidase for 1 hour at room temperature and analyzed using enhanced chemiluminescence (PerkinElmer Life Sciences, Waltham, MA). Blots were reprobed for β-tubulin (Sigma), and results were normalized to correct for loading.
mRNA Analysis
Total mRNA was extracted from tissue using RNeasy mini kit (QIAGEN Sciences, Germantown, MD). cDNA was synthesized from 1.5 µg RNA with first-strand cDNA synthesis kit (GE Healthcare, Piscataway, NJ). Polymerase chain reaction amplification was performed in duplicate using the ABI Prism 7000 sequence detection system (Life Technologies, Foster City, CA) and using the comparative threshold cycle method to determine mRNA levels. The gene expression data were normalized to 18S rRNA levels. Polymerase chain reaction amplification to detect SGK1, ENaC, and 18S rRNA levels was performed with TaqMan gene expression assays. Data are represented as fold increases relative to the measurement in wild-type (WT) mice.
Zona Glomerulosa Cell Stimulation
Adrenal glands were excised during euthanization, and zona glomerulosa cells were isolated as previously reported. 17 Zona glomerulosa cell suspensions were made by diluting pellets to obtain 1 to 2×10 5 cells/0.5 mL of modified Krebs-Ringer bicarbonate. Cells were then incubated in duplicate, vehicle, or in the presence of angiotensinogen II (10 -7 mol/L) for 1 hour at 37°C under % CO 2 and 95% O 2 atmosphere. Aldosterone levels were measured using Coat-A-Count Radioimmunometric Assay kit as listed above.
HyperPATH Cohort and Study Protocol
Our analysis consisted of 366 hypertensive white subjects from the Hypertensive Pathotype (HyperPATH) Cohort, a cohort designed to determine the genetic underpinnings of hypertension, as previously extensively reported. A detailed description of the study protocol and cohort methods can be found in the online-only Data Supplement.
Human Study Genotyping
DNA was extracted as previously described.
18,19
Statistical Analysis
Animal Study
All values are reported as means±SEM unless otherwise indicated, and corrections for multiple comparisons are made where appropriate. Within each genotype, paired Student t tests were used to determine the significance of the increase in systolic BP when intake was changed from ResS to LibS diets. Student nonparametric t test was used when comparing various parameters between WT and Strn +/− mice on either a LibS or ResS diet. A difference was considered statistically significant if a 2-tailed was ≤0.05. Because the biomarkers came from different mice on the 2 diets, nonparametric tests were used and the nominal P value was adjusted for multiple comparisons (P≤0.025). All studies were completed with the individual performing the study blinded as to genotype and diet, which the tissue or samples were obtained.
Human Study
Given the large number of single nucleotide polymorphisms (SNPs) identified via HapMap, haplotypes were constructed from the genotyping of this cohort using the Haploview program 4.1. 20 All subsequent analyses are described in Methods in the online-only Data Supplement.
Results
Striatin Modulates Rapid, Nongenomic MR Activity
We first examined the in vitro rapid effects of aldosterone (50 nmol/L) in EA.hy926 cells, an endothelial cell line. Our results show that increases in pAkt/Akt protein ratio is time dependent, with the highest increase in activation at 15 minutes and rapid return to baseline thereafter ( Figure 1A ). Next, we tested whether decreasing striatin levels through the use of siRNA technology would affect pAkt/Akt activation. In EA.hy926 cells, striatin siRNA reduced striatin levels and inhibited the rapid effects of aldosterone/MR signaling ( Figure 1B) .
Generation of Strn +/− Mice
To investigate the physiological relevance of rapid, nongenomic MR activation, striatin gene targeting was performed by the International Knockout Mouse Consortium in JM8 embryonic stem cell line on a C57BL/6 N genetic background (online-only Data Supplement). Immunoblotting analysis of Strn +/− mouse tissues (adrenal, heart, and kidney) confirmed that targeted allele effectively reduced striatin protein levels ( Figure 2) Figure 3 ). Next, we assessed the impact of dietary sodium intake on the level of activation of the renin-angiotensin-aldosterone system by measuring the levels of plasma renin activity and aldosterone at the time of euthanization. Although plasma renin activity levels were significantly reduced on the LibS versus ResS diets, there were no differences between genotypes ( Figure 4A and 4B). Interestingly, aldosterone levels were significantly higher on a LibS diet in Strn +/− mice compared with that in WT ( Figure 4C and 4D). Furthermore, we measured aldosterone production in response to angiotensin II stimulation ex vivo in an isolated glomerulosa cell system. Similar to plasma measurements, aldosterone production was significantly lower on LibS versus ResS diets. Angiotensin II stimulation induced a ≈2-fold increase in aldosterone on ResS diets, but there were no significant differences between genotypes ( Figure 4C ).
Heart and Kidney Tissue Analysis
Heart weight and heart/body weight ratios did not differ between WT and Strn +/− mice whether on a ResS diet (4.8±0.2 and 4.9±0.2 mg/g, respectively) or on a LibS diet (4.4±0.2 and 4.2±0.2 g, respectively). However, as anticipated from the cell-based studies, phosphorylation of Akt in heart tissue was significantly (P<0.05) reduced (≈70%) in Strn +/− mice compared with WT animals on the same diet ( Figure 5A ).
Similar to the heart, kidney weight and kidney/body weight ratios did not differ between WT and Strn +/− mice whether on a ResS diets (5.8±0.3 and 5.3±0.2 mg/g, respectively) or on a LibS diets (5.5±0.2 and 5.7±0.2 mg/g, respectively), whereas the pAkt/Akt ratio in kidneys obtained from mice on a LibS diet was significantly lower (P=0.01) in the Strn +/− mice compared with the WT mice ( Figure 5B ). In contrast, MR transcript levels on a LibS diet were significantly increased (≈1.7 fold; P=0.01) in Strn +/− versus WT mice ( Figure 5C ). This increased MR expression level was associated with differences in the expression of known MR-activated downstream genes: Strn +/− mice had significantly (P<0.01) higher mRNA transcript levels of SGK1 (≈1.4-fold) and ENaC (>5-fold) compared with WT animals on the same diet ( Figure 5D and 5E).
Human Study Participant Characteristics
To assess the relevance of the findings in mice to humans, the association between known SNP variation in the striatin gene and salt-sensitive BP in humans was assessed. Study participant characteristics are summarized in the online-only Data Supplement (Table S2 ). There were 366 white individuals from the HyperPATH cohort examined. Genotyping had a completion rate of ≥95%, and all SNPs were in Hardy-Weinberg equilibrium. Of the 40 HapMap-derived SNPs genotyped in the STRN gene, 21 were removed before the start of the analysis (7 displayed monomorphism in our population and 14 had a minor allele frequency of <0.03). The remaining 19 SNPs captured 100% of the common HapMap white variation in this region and were contained in 3 distinct haplotype blocks (Table S3 ). A haplotype analysis (Table) was first conducted to determine the association of each of the 3 haplotype blocks with salt-sensitive BP. The global block analysis was significantly associated with SS of BP (P global =0.04). This association was entirely driven by haplotype number 3 rs2540923A|rs8880 83G|rs11678303G|rs6744560A|rs7562109A|rs10490658A| rs7573966A (P=0.002) and specifically the first SNP within that haplotype (rs2540923). The relationship of the rs2540923 SNP with SS of BP was then assessed (Figure 6 ). Adjusting for age, sex, and body mass index, minor allele carriers (AG/ AA) for rs2540923 displayed 6-fold increased odds ratio for SS of BP versus major allele homozygotes (odds ratio, 6.25; 95% confidence interval, 1.70-20). There were no genotypeassociated differences in aldosterone levels either on the LibS or on the ResS intakes.
Discussion
Knocking down the striatin gene in mice and polymorphic variants of the striatin gene in humans is associated with SS of BP. In the mice, SS is not related to an alteration in aldosterone production but may be related to alteration in its metabolism and effectiveness. MR expression in the kidney is increased as are the levels of expression of 2 downstream targets of MR activation, SGK1 and especially ENaC. Importantly, in both the kidney and the heart, a signature for a defect in aldosterone's rapid, nongenomic pathway-decrease phosphorylation of Akt-is present. From this and a previous study, we have documented that dietary sodium restriction (that increases aldosterone) and direct aldosterone administration increases MR expression. Thus, on a liberal salt diet, one would expect a decrease in the expression of MR, SGK1, and ENaC. This did not occur in Strn +/− mice, suggesting that striatin plays a role, as yet undefined, in modulating the normal effect of salt intake on this cascade. The net result is an inappropriately increased activity of sodium retaining mechanisms on a liberal salt diet and SS of BP.
Our previous studies documented in EA.hy926 cells, endothelial cell cultures that (1) striatin coimmunoprecipitates with MR in vitro and in vivo; (2) aldosterone stimulates rapid phosphorylation of ERK1/2 that is prevented by knocking down striatin with siRNA; (3) aldosterone stimulates striatin synthesis; and (4) knocking down striatin in vitro does not modify the transcript levels of classical genomic targets of aldosterone, eg, SGK1 and ENaC. In the present study, the cell culture data extend the molecules involved in striatinassociated effects to include Akt. 13, 21 Furthermore, the in vivo studies document that knocking down striatin levels has the same effect in the heart and kidney as in endothelial cellsreduction in phosphorylation of Akt.
To date, the data supporting a role for striatin as a critical intermediate in the nongenomic effects of steroid hormones in general and aldosterone in particular have come from in vitro studies. The current study extends this support to the in vivo state and suggests that striatin is involved in regulating the organism's BP response to sodium intake. 22 The mechanism(s) by which alterations in striatin lead to SS of BP does not seem to be related to genotype-driven differences in plasma renin activity levels in humans (minor allele carriers of rs2540923) or Strn +/− mice or potassium levels in humans. Also, the biosynthesis in aldosterone from glomerulosa cells does not differ by genotype in the mice either with a change in sodium diet or in response to incubation with angiotensin II. Thus, striatin does not seem to be involved in mediating the external signals regulating aldosterone secretion or its de novo production by glomerulosa cells. However, the effectiveness of aldosterone seems to be increased as documented by 3 changes in the kidneys of the Strn +/− mice: a significant increase in renal MR mRNA expression associated with increased SGK1 and ENaC mRNA expressions. Thus, the data from this study suggest that excess MR activity underlies the SS of BP phenotype observed in Strn +/− mice. Excess MR expression could potentially come from the increased circulating aldosterone levels in the Strn +/− mice studied on the LibS diet. Given the absence of an effect on the production of aldosterone in the Strn +/− mice, altered metabolism may be the mechanism for the increased circulating aldosterone. How this effect occurs, is uncertain. These results raise the possibility that the excess volume expansion leading to SS of BP in Strn +/− mice is secondary to increased renal expression of MR leading to increased SGK1 and ENaC and thus increased ENaC-mediated reabsorption of sodium in the renal collecting tubules.
An increasing body of data supports the concept that hypertension is not a disease but a heterogeneous syndrome, with several pathways leading to an increase in BP and more specifically to salt-sensitive hypertension. Thus, Genome-Wide Association Studies (GWAS) have been nearly uniformly unsuccessful in identifying risk genes and alleles, likely because of the heterogeneity of the patient population used. Thus, it is not surprising that there was no signal on 2p22.2 in the CHARGE and Global BP GWAS studies, given the low frequency of the risk allele, the heterogeneity of the population, and the lack of control of environmental factors critical for identifying the intermediate phenotype identified in this study.
There are limitations to these studies. First, in the human gene association study, the sample size is relatively small, which could play a role in driving our positive findings. However, the study is strengthened by the strict environmental control imposed (medication washout, calculated diets, standardization in procedures, and use of a central laboratory). 23 SNP rs2540923 is a tagging SNP and therefore likely is a marker in linkage disequilibrium with the functional SNP. Given the nature of the phenotype and the fact that this SNP is not in the coding region of the gene, it is suggested that the functional SNP is likely in the regulatory region of the gene. Given the similarity between the mouse and the human phenotypes, it is likely that the functional SNP leads to a decrease in the expression of striatin, although there is no direct data to support this hypothesis. Second, our cohort was restricted to whites, and additional studies are required to determine whether this phenotype will be observed in other racial groups. Third, in contrast to the mice studies, the human studies did not demonstrate a difference in aldosterone levels on the LibS diet. This lack of difference could be related to the level of expression of striatin associated with the polymorphic variants in the gene and other differences in the protocols used. Fourth, in the mice studies, although the molecular data are suggestive of the mechanism involved in the SS of BP, the evidence is somewhat indirect, particularly because of the differential effects on SGK1 levels between the culture endothelial cells and the Strn +/− mice. In addition, protein levels were not assessed for MR, SGK1, or ENaC in this study, but others have suggested a correlation between changes in protein and mRNA of these molecules. However, it has previously been suggested that the nongenomic MR pathway may interact with genomic mechanisms to provide an integrated cellular response. 5 Such would be more likely observed in vivo than in vitro. Finally, all generalized knockout models experience the possibility that the observed phenotype is because of an effect in another disrupted gene or an effect in another tissue.
Perspectives
Striatin is a novel protein that interacts with and modulates the rapid, nongenomic activity of steroid receptors, including the MR; however, its role in sodium, water, and BP homeostasis is unknown. In the present study, we provide direct support for a role of striatin in modulating the organism's response to salt intake and suggest that an alteration in the MR and its downstream targets in the kidney may be the responsible mechanism(s). However, further studies are needed to elucidate the pathophysiological effects of striatin gene variants deficiency and whether striatin SNPs can be exploited to identify individuals who would benefit from sodium restriction and specific antihypertensive therapies. What Is Relevant?
• Salt-sensitive hypertension is a major, heterogeneous subset of the hypertensive population whose cause(s) is (are) largely unknown. Identifying the underling mechanisms in the homogeneous subgroups of this subset will aid in the development of more precise and specific treatment and prevention strategies. Variants in the expression of the striatin gene may underlie one of these homogeneous subgroups.
Summary
In a novel striatin heterozygous knockout mouse, we demonstrated that reduction in striatin levels results in salt sensitivity of blood pressures and on a liberal salt diet was associated with increased plasma aldosterone levels and renal tissue expression of mineralocorticoid receptor, serum/glucocorticoid-regulated kinase, and epithelial sodium channel. Using a well-phenotyped white hypertensive cohort, we documented that genetic variance within the striatin gene was associated with salt sensitivity of blood pressures. Taken together, this study supports a role for striatin in modulating the response to salt intake and proposes that an alteration in mineralocorticoid receptor and its downstream targets may be the possible mechanism. Figure S1 ). GenBank file available at http://www.knockoutmouse.org.
2
Embryonic stem (ES) cells (JM8.F6) were created from C57BL/6N mice with a/a (black on the 3 "agouti gene" and no TyrC (non albino) on the "color gene." Chimeras derived from the 4 injection of (a/a) ES cells in to BALB/c host embryo had black, agouti, and white coat color.
5
Percent chimerism was determined by % of black and agouti coat color. Chimaeras generated 6 were bred to C57BL/6N mice, thus maintaining the mutations on an isogenic background.
7
Chimeric males then were mated with C57BL/6N females, and off spring with a black coat color Table S1 . There were no significant differences between the Strn However, it has been frequently documented that anesthesia activates several of the hormonal 7 systems that independently can effect blood pressure. Telemetry reduces and/or eliminates 8 several of the issues raised with the tail cuff approach for providing sensitive, accurate, long term 9 data in the animal's natural environment. However, because telemetry is invasive, damage to the 10 vasculature (particularly with long term studies) and animal deaths are two risks. Our study was 11 performed over a 14 day period and therefore, we elected to use the tail cuff approach. In our Human Study Participants and Protocol (HyperPath Cohort) 16 Our analysis consisted of 366 hypertensive Caucasian subjects from the Hypertensive Pathotype Table   24 S1. The Institutional Review Board at each participating study site approved the study protocol 25 and written informed consent was obtained for all subjects.
27
Inclusion and exclusion criteria and the phenotyping protocol for the HyperPATH Cohort have 28 been described in detail previously 3 . In brief, subjects used in this analysis had normal history, 29 physical, and laboratory examinations except for hypertension. All subjects were between 18 to 30 65 years old and race was self-defined. Hypertension was defined as a seated DBP of ≥ 100 mm 
Human Study Statistical Analysis
4
Associations between SS BP and haplotypes within the striatin gene were assessed using PLINK . Bonferroni correction was applied to account for multiple testing for the 3 haplotypes.
6
Therefore a P-value ≤ 0.02 (0.05/3) was considered statistically significant. We then explored outcome, genotype of the SNP as the primary predictor, BMI, age, sex, and study site as fixed 13 effects, and relatedness of individuals as a random (cluster) effect. Different genetic models of 14 inheritance (dominant, recessive, and additive) for SS BP risk allele were tested for candidate 15 SNPs. 16 
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DNA Genotyping
18
Tagging SNP selection criteria included minor allele frequencies greater than 0.1 at R 2 ≥ 0. 
